Brand names: Brevital®
Chemical formula:

Methohexital Sodium Solution for injection
What is this medicine?
METHOHEXITAL (meth oh HEK si tal) is an anesthetic. It is used to cause relaxation and sleep before or during surgery. It does not relieve pain.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
heart disease
liver disease
porphyria
seizures
an unusual or allergic reaction to methohexital, other barbiturates, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
breast-feeding
How should I use this medicine?
This medicine is for infusion into a vein or injection into a muscle. This medicine can be diluted and prepared as an enema to be given rectally. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for children as young as 1 month old for selected conditions, precautions do apply.
Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.
NOTE: This medicine is only for you. Do not share this medicine with others.
What if I miss a dose?
If you miss a dose, use it as soon as you can. If it is almost time for your next dose, use only that dose. Do not use double or extra doses.What may interact with this medicine?
Do not take this medicine with any of the following medications:
MAOIs like Carbex, Eldepryl, Marplan, Nardil, and Parnate
St. John's wort
voriconazole
This medicine may also interact with the following medications:
alcohol
ethyl alcohol
levodopa
medicines for seizures like phenobarbital
medicines for sleep
medicines that treat or prevent blood clots like warfarin, enoxaparin, and dalteparin
narcotic medicines for pain
propylene glycol
steroid medicines like prednisone or cortisone
This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.
What should I watch for while using this medicine?
Your condition will be monitored carefully while you are receiving this medicine.
You may get drowsy or dizzy. Do not drive for at least 8 to 12 hours after you are treated with this medicine. Do not use machinery, or do anything that needs mental alertness until you know how this medicine affects you. Do not stand or sit up quickly, especially if you are an older patient. This reduces the risk of dizzy or fainting spells. Alcohol may interfere with the effect of this medicine. Avoid alcoholic drinks.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
breathing problems
fast, irregular heartbeat
feeling faint or lightheaded, falls
low blood pressure
muscle twitch
numbness or tingling in the hands or feet
pain at site where injected
seizures
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
anxietyor confusion
coughing
headache
hiccups
nausea, vomiting
This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
Last updated: 7/1/2002
Important Disclaimer: The drug information provided here is for educational purposes only. It is intended to supplement, not substitute for, the diagnosis, treatment and advice of a medical professional. This drug information does not cover all possible uses, precautions, side effects and interactions. It should not be construed to indicate that this or any drug is safe for you. Consult your medical professional for guidance before using any prescription or over the counter drugs.
| Systematic (IUPAC) name | |
|---|---|
| 5-hex-3-yn-2-yl-1- methyl-5-prop-2-enyl-1, 3-diazinane-2,4,6-trione | |
| Clinical data | |
| AHFS/Drugs.com | Consumer Drug Information |
| Pregnancy cat. | B (USA) |
| Legal status | Schedule IV |
| Routes | Intravenous, rectal |
| Pharmacokinetic data | |
| Bioavailability | I.V. ~100% Rectal ~17% |
| Metabolism | Hepatic |
| Half-life | 5.6 ± 2.7 minutes |
| Excretion | ? |
| Identifiers | |
| CAS number | 151-83-7 |
| ATC code | N01AF01 N05CA15 |
| PubChem | CID 9034 |
| DrugBank | DB00474 |
| ChemSpider | 8683 |
| UNII | E5B8ND5IPE |
| KEGG | D04985 |
| ChEBI | CHEBI:102216 |
| ChEMBL | CHEMBL7413 |
| Chemical data | |
| Formula | C14H18N2O3 |
| Mol. mass | 262.304 |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Methohexital, also called methohexitone, (marketed under the brand name Brevital) is a drug which is a barbiturate derivative. It is classified as short-acting, and has a rapid onset of action. It is similar in its effects to sodium thiopental, a drug with which it competed in the market for anaesthetics.
|
Contents
|
Methohexital binds to a distinct site which is associated with Cl− ionophores at GABAA receptors.[1] This increases the length of time which the Cl− ionopores are open, thus causing an inhibitory effect.
Metabolism of methohexital is primarily hepatic (i.e., taking place in the liver) via demethylation and oxidation.[citation needed] Side-chain oxidation is the primary means of metabolism involved in the termination of the drug's biological activity.
Protein binding is approximately 73% for methohexital.[citation needed]
Methohexital is primarily used to induce anesthesia, and is generally provided as a sodium salt (i.e. methohexital sodium). It is only used in hospital or similar settings, under strict supervision.[citation needed] It has been commonly used to induce deep sedation, "twilight sleep" or general anesthesia for oral surgery and dentistry. It is also used to induce anesthesia prior to ECT (electroconvulsive therapy).
Methohexital, 5-allyl-1-methyl-5-(1-methyl-2-pentinyl barbituric acid, is synthesized in the classic manner of making barbituric acid derivatives, in particular by the reaction of malonic ester derivatives with derivatives of urea. The resulting allyl-(1-methyl-2-pentynyl) malonic ester is synthesized by subsequent alkylation of the malonic ester itself, beginning with 2-bromo-3-hexyne, which gives (1-methyl-2-pentynyl)malonic ester, and then by allylbromide. In the final step, reaction of the disubstituted malonic ester with N-methylurea gives desired methohexital. ![]()
W.J. Doran, U.S. Patent 2,872,448 (1959).
|
||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)